February 6, 2026

Semler Scientific, Inc. (SMLR) Stock Analysis: Exploring a 258.65% Potential Upside

In the dynamic world of healthcare technology, Semler Scientific, Inc. (NASDAQ: SMLR) stands as a notable contender within the medical devices industry. Headquartered in Santa Clara,..

Community Health Systems, Inc. (CYH) Stock Analysis: Evaluating a 17.95% Potential Upside in a Challenging Healthcare Sector

Community Health Systems, Inc. (NYSE: CYH) presents a complex investment landscape for those interested in the healthcare sector, particularly within the medical care facilities industry. As..

Day One Biopharmaceuticals, Inc. (DAWN): A Stock with Over 116% Potential Upside – Investor Outlook

Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN) stands out in the biotechnology industry with its innovative approach to tackling both childhood and adult diseases. With a market..

Tilray Brands, Inc. (TLRY) Stock Analysis: Exploring a 67.73% Potential Upside in the Cannabis Sector

Investors looking to diversify their portfolios with a stake in the burgeoning cannabis industry might find Tilray Brands, Inc. (TLRY) an intriguing prospect. As a prominent..

Claritev Corporation (CTEV) Stock Analysis: Unveiling 122.76% Potential Upside for Investors

Claritev Corporation (CTEV), a pivotal player in the healthcare sector, is drawing significant attention from investors with its compelling potential upside. With a market capitalization of..

Keros Therapeutics (KROS) Stock Analysis: A Promising Prospect with 36% Upside Potential

Keros Therapeutics, Inc. (NASDAQ: KROS) presents a compelling investment opportunity within the biotechnology sector, marked by a notable 36.31% potential upside, according to current analyst ratings...

AxoGen, Inc. (AXGN) Stock Analysis: Exploring the 10.13% Potential Upside with Strong Buy Ratings

AxoGen, Inc. (NASDAQ: AXGN), a prominent player in the healthcare sector specializing in medical devices, is currently capturing the attention of individual investors with its innovative..

Dianthus Therapeutics, Inc. (DNTH) Stock Analysis: Exploring a 54.96% Upside Potential

Dianthus Therapeutics, Inc. (NASDAQ: DNTH) stands out in the biotechnology sector, capturing the attention of investors with a market cap of $2.01 billion and a promising..

Sonida Senior Living, Inc. (SNDA) Stock Analysis: Navigating Growth Amidst Challenging Valuations

Sonida Senior Living, Inc. (SNDA) stands as a notable player within the healthcare sector, specifically focusing on medical care facilities in the United States. With a..

LifeMD, Inc. (LFMD) Stock Analysis: Discovering a Potential 233.94% Upside in the Telehealth Revolution

LifeMD, Inc. (NASDAQ: LFMD) is making waves in the healthcare sector as a direct-to-patient telehealth provider poised for significant growth. With its market cap standing at..

Upstream Bio, Inc. (UPB) Stock Analysis: Exploring an 83% Potential Upside in Biotech Innovation

Upstream Bio, Inc. (NASDAQ: UPB) has captured the attention of investors within the biotechnology sector, primarily due to its promising pipeline and significant potential upside. As..

AMN Healthcare Services Inc (AMN) Stock Analysis: Navigating Challenges and Opportunities in Healthcare Staffing

AMN Healthcare Services Inc (AMN) is a prominent player in the U.S. medical care facilities industry, providing a range of workforce solutions and staffing services to..

Xencor, Inc. (XNCR) Stock Report: Analysts Predict 166% Upside Potential

Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company, is making waves in the healthcare sector with its robust pipeline of engineered monoclonal antibodies. As Xencor focuses..

Geron Corporation (GERN) Stock Analysis: Uncovering a 132.88% Potential Upside in Biotech

For investors with an appetite for high-risk and high-reward opportunities, Geron Corporation (NASDAQ: GERN) presents an intriguing case within the biotechnology sector. With its focus on..

Ginkgo Bioworks Holdings, Inc. (DNA) Investor Outlook: Understanding the 20% Potential Upside Amidst Challenges

Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) stands at the intersection of biotechnology and innovation, offering investors a glimpse into the future of cell programming. Despite a..

Kura Oncology, Inc. (KURA): Growth Potential with a 338.58% Upside and Strong Buy Ratings

Kura Oncology, Inc. (NASDAQ: KURA) stands out in the biotech sector with its promising drug pipeline aimed at tackling some of the most challenging oncological diseases...

Embecta Corp. (EMBC) Stock Analysis: Navigating a 59% Potential Upside Amid Healthcare Innovations

Embecta Corp. (NASDAQ: EMBC), a prominent player in the healthcare sector, specifically within the Medical Instruments & Supplies industry, is poised for an intriguing journey. With..

Collegium Pharmaceutical, Inc. (COLL) Stock Analysis: A 13.31% Upside with Strong Buy Ratings

Collegium Pharmaceutical, Inc. (NASDAQ: COLL), a key player in the specialty pharmaceutical sector, focuses on developing and commercializing innovative pain management solutions. With a market capitalization..

ArriVent BioPharma, Inc. (AVBP) Stock Analysis: Exploring an 88.45% Potential Upside

ArriVent BioPharma, Inc. (NASDAQ: AVBP) is emerging as a compelling player in the biotechnology sector, capturing the attention of investors with its promising pipeline and significant..

Theravance Biopharma Inc. (TBPH) Stock Analysis: Unveiling a 36% Potential Upside

Theravance Biopharma, Inc. (NASDAQ: TBPH) stands out in the biotechnology sector with its promising product pipeline and strategic collaborations. With a market capitalization of $992.17 million,..

Search

Funds

February 6, 2026

Search

Funds

February 6, 2026

FTSE 100

Funds